Anderson Woodrow D has filed 8 insider transactions across 1 company since February 2026.
Most recent transaction: a option exercise of 5946 shares of Indivior Pharmaceuticals, Inc. ($INDV) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | M | Restricted Stock Units | 5946 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.00% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | F | Common Stock | 2682 | $31.98 | 24,638.0000 | 125,000,000 | 9.82% | 0.00% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | M | Performance Stock Units | 23975 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.02% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | M | Common Stock | 18364 | $0.00 | 29,657.0000 | 125,000,000 | 162.61% | 0.01% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | F | Common Stock | 8283 | $31.98 | 21,374.0000 | 125,000,000 | 27.93% | 0.01% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | M | Common Stock | 5946 | $0.00 | 27,320.0000 | 125,000,000 | 27.82% | 0.00% |
| Feb. 9, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | A | Performance Stock Units | 23975 | $0.00 | 23,975.0000 | 125,000,000 | 9999.99% | 0.02% |
| Feb. 10, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Anderson Woodrow D | Chief Accounting Officer | A | Common Stock | 6903 | $0.00 | 11,293.0000 | 125,000,000 | 157.24% | 0.01% |